Virtu Financial’s ProShares UltraShort NASDAQ Biotechnology BIS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-4,767
| Closed | -$319K | – | 1452 |
|
|
2019
Q1 | $319K | Buy |
+4,767
| New | +$319K | 0.02% | 744 |
|
|
2018
Q4 | – | Sell |
-8,724
| Closed | -$545K | – | 1550 |
|
|
2018
Q3 | $545K | Buy |
8,724
+4,970
| +132% | +$310K | 0.03% | 552 |
|
|
2018
Q2 | $292K | Sell |
3,754
-3,244
| -46% | -$252K | 0.02% | 1170 |
|
|
2018
Q1 | $592K | Sell |
6,998
-11,603
| -62% | -$982K | 0.03% | 614 |
|
|
2017
Q4 | $1.64M | Buy |
18,601
+10,786
| +138% | +$952K | 0.09% | 254 |
|
|
2017
Q3 | $643K | Buy |
7,815
+2,872
| +58% | +$236K | 0.03% | 721 |
|
|
2017
Q2 | $479K | Sell |
4,943
-1,508
| -23% | -$146K | 0.07% | 216 |
|
|
2017
Q1 | $719K | Buy |
6,451
+849
| +15% | +$94.6K | 0.07% | 179 |
|
|
2016
Q4 | $784K | Buy |
+5,602
| New | +$784K | 0.08% | 185 |
|
|
2016
Q3 | – | Sell |
-16,365
| Closed | -$2.72M | – | 369 |
|
|
2016
Q2 | $2.72M | Sell |
16,365
-9,375
| -36% | -$1.56M | 0.36% | 52 |
|
|
2016
Q1 | $4.49M | Buy |
+25,740
| New | +$4.49M | 0.62% | 32 |
|
|
2015
Q4 | – | Sell |
-36,388
| Closed | -$5.61M | – | 368 |
|
|
2015
Q3 | $5.61M | Buy |
36,388
+31,328
| +619% | +$4.83M | 0.73% | 29 |
|
|
2015
Q2 | $581K | Buy |
+5,060
| New | +$581K | 0.05% | 187 |
|
|
2014
Q4 | – | Sell |
-928
| Closed | -$224K | – | 299 |
|
|
2014
Q3 | $224K | Buy |
+928
| New | +$224K | 0.02% | 249 |
|